Limited 4 MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2020 3. Financial highlights (based on Thai FRS) Q1 2020 Financial Position Summary as of 31 March 2020 compared to Q1 2019: Note

operating results Details as follows: Performance summary (Summary Table) Unit: Million Baht Q2/2019 Q2/2020 %change 6M/2019 6M/2020 % change Revenue from contracts with customers 91.8 87.0 -5.2% 181.7 184.1

debt instruments (surveillance report – on a monthly basis)) ✓ ✓ 1. Database of SET Smart (the summary of trading and important statistics on debt instruments and bonds from the Stock Exchange) 3

value is derived from this method of calculation, whereby the calculation is based on the Company’s reviewed consolidated financial statements as of 30 September 2017. When combining with the transaction

prior to the exercise date; Clause 10 The number of newly issued underlying shares applied for an offer for sale, combining with those provided by a company as underlying shares of convertible bonds or

accounts. The Company’s Board of Directors has considered and resolved that the price of the investment disposition was appropriate. Summary of SBITO’s financial statements as of September 30, 2017 are as

Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company

Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company

Ref U. SET 017/2017 7 August 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 2/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and its

report and consolidated financial statements 2) A summary of the operating results of the listed company and its subsidiaries for the second quarter of the year 2017 (F45-3) Jasmine International Public